The gap between a 3.1% ROE in 2026Q3 and Equifax's 16.2% appears structural rather than cyclical, since goodwill represents roughly 48% of TransUnion's $12.1B asset base and inflates the invested capital against which ROIC is measured. That said, the ROIC path is at least flat-to-improving off a 1.3% low in 2024Q3, suggesting the cloud migration and Neustar integration may be starting to work through the cost base, though a full-cycle ROIC nearer to EFX's level would require sustained margin expansion. Investors should treat the low reported ROIC as partially an accounting artifact of acquisition accounting and partially a genuine signal that capital deployed in the last M&A cycle is not yet earning a competitive return.

The simultaneous decline in debt-to-equity from 1.26 to 1.09 and compression in D/EBITDA appears driven by both debt paydown and EBITDA growth, which is a healthier deleveraging profile than one relying on a single lever. However, coverage of 4.14x is still thinner than would be comfortable for a business whose highest-margin revenue stream (mortgage-linked credit pulls) is cyclically depressed, and the 12.66x D/EBITDA remains elevated against the low-single-digit leverage that rating agencies typically favor for data oligopolies. Refinancing risk looks manageable at current coverage but would warrant close monitoring if coverage were to fall back toward the 2024Q3–2024Q4 range of 2.45x–2.78x.

Asset turnover of 0.11x, while up modestly from 0.09x in 2024Q2, remains structurally low and consistent with an intangible-heavy, capital-light data business rather than an operating-efficiency story. The DPO expansion has been a meaningful contributor to the recovery in free cash flow seen through 2026Q3, which suggests part of the cash conversion improvement is timing-driven rather than a durable efficiency gain. Given that DIO is unavailable in the reported data, the full cash conversion cycle cannot be computed, so the DPO-led picture should be interpreted with that limitation in mind.

The wide trailing-to-forward gap most likely reflects depressed trailing GAAP earnings from non-operating and tax items rather than an unambiguous doubling of operating earning power, so the headline forward multiple may flatter the underlying economics. On EV/EBITDA, at 13.09x current versus 11.07x forward, TRU trades at a modest discount to Equifax's 14.08x, which is defensible given TRU's lower ROIC (2.1% versus 8.5%) and higher absolute leverage. The P/B of 3.26x versus EFX's 4.60x appears to reflect the market pricing in both the weaker return profile and the goodwill concentration, rather than a value opportunity.

The gross margin recovery from the anomalous 46.2%–46.5% levels in mid-2025 back to ~59% for five straight quarters appears consistent with a discrete, possibly non-recurring cost event rather than a permanent structural shift, and should not be extrapolated as pricing improvement. Operating margin expansion to 20.4% alongside revenue growth of 12.2% in 2026Q3 suggests genuine operating leverage from overhead discipline, but the persistent 8–12 point spread between operating margin and net margin reflects the amortization and interest burden of the acquisition-heavy strategy. On a normalized view, operating margin is the more reliable indicator of TransUnion's earning power at this stage, since net margin volatility appears driven substantially by non-operating items.